MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-12-2025
Dyadic International DIO Ratio 2011-2026 | DYAI
Annual DIO Ratio Dyadic International
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | 161 | 105 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 161 | 105 | 133 |
DIO Ratio of other stocks in the Biotechnology industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AstraZeneca PLC
AZN
|
206 | $ 93.52 | -1.2 % | $ 96.9 B |  Britain |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
512 | - | - | $ 40.3 B |  USA |
 |
Biogen
BIIB
|
394 | $ 184.48 | -1.67 % | $ 26.9 B | USA |
 |
Midatech Pharma plc
MTP
|
40.6 | - | -18.52 % | $ 27.3 M | Britain |
 |
Институт стволовых клеток человека
ISKJ
|
275 | - | - | - |  Russia |
 |
Acasti Pharma
ACST
|
136 | - | 4.01 % | $ 150 M |  Canada |
 |
Catalyst Biosciences
CBIO
|
410 | $ 10.84 | 0.46 % | $ 714 M | USA |
 |
Corcept Therapeutics Incorporated
CORT
|
338 | $ 37.35 | -0.4 % | $ 3.86 B | USA |
 |
Catalyst Pharmaceuticals
CPRX
|
93.3 | $ 23.18 | 2.02 % | $ 2.75 B | USA |
 |
Albireo Pharma
ALBO
|
26.1 | - | -0.23 % | $ 916 M | USA |
 |
Cellectis S.A.
CLLS
|
23.3 | $ 4.22 | -4.2 % | $ 116 M |  France |
 |
Amphastar Pharmaceuticals
AMPH
|
132 | $ 29.43 | 6.09 % | $ 1.43 B | USA |
 |
Acorda Therapeutics
ACOR
|
345 | - | -24.86 % | $ 820 K | USA |
 |
Arena Pharmaceuticals
ARNA
|
160 | - | -6.81 % | $ 3.04 B | USA |
 |
Abeona Therapeutics
ABEO
|
265 | $ 5.14 | -1.06 % | $ 110 M | USA |
 |
Axon Enterprise
AXON
|
116 | $ 632.29 | 0.09 % | $ 47.9 B | USA |
 |
ADiTx Therapeutics
ADTX
|
220 | $ 0.81 | 1.96 % | $ 10.7 K | USA |
 |
Aytu BioScience
AYTU
|
209 | $ 2.7 | 2.27 % | $ 17 M | USA |